Palantir was founded with the help of CIA-backed investment fund In-Q-Tel and it attracted controversy by providing digital profiling tools for the CIA and US immigration agency ICE.

Tech giant started by US billionaire 'clinches' £480m deal to handle NHS patient information Company founded by Republican party donor Peter Thiel understood to have won lucrative, history-making ...

Controversial big data analytics firm Palantir has been awarded the £0.5 billion contract to create an NHS patient data platform, pending ministerial approval, according to health news website ...

Palantir, the $160 billion (€152 billion) US surveillance company at the centre of the farrago around suspended Social Democrats TD Eoin Hayes, is no stranger to controversy.

NHS probes potential contract breach by Palantir's unauthorized marketing campaign. Palantir's influencer initiative aimed to counter criticism and alleged misinformation. Get ahead of Wall Street ...

Palantir Stock Has Surged, but Some See Growing Reputational Risks Palantir is up 80% in 2025 amid new reports questioning its work for the US government.

NHS England has awarded a new contract to US data analytics company Palantir to transition existing NHS projects into a new federated data platform (FDP), prompting pushback from organisations ...

NHS staff and medical trade unions have voiced concerns about Palantir ’s suitability for managing data in national health systems, given it is best known for its ties to the security, defence ...

Palantir has strong earnings, has potential for S&P 500 inclusion, and its AI Platform shows strong demand. Find out if PLTR stock is a buy.

The NHS Federated Data Platform has been rolled out to more than 100 NHS organisations in its first year, according to NHS England. The platform, which has created controversy since its inception ...